Patents by Inventor Jay Soto

Jay Soto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSING REGIMES FOR TREATMENT OF SYNUCLEINOPATHIES
    Publication number: 20210079103
    Abstract: The invention provides dosage regimes for treatment of synucleinopathies. In one regime, a subject receives 3000-5000 mg of an antibody intravenously every 3-5 weeks. In another regime, a subject receives 1300-1700 mg of an antibody intravenously every 3-5 weeks.
    Type: Application
    Filed: July 23, 2020
    Publication date: March 18, 2021
    Inventors: Jay Soto, Daniel Keith Ness, Martin Koller, Diane Mould, Frank Boess, Meret Martin-Facklam, Valerie Cosson, Hans Peter Grimm, Ronald Gieschke, Sara Belli, Silke Weber
  • LYOPHILIZED FORMULATION OF A MONOCLONAL ANTIBODY AGAINST TRANSTHYRETIN
    Publication number: 20200362023
    Abstract: The invention provides antibody formulations and methods useful for prophylaxis or treatment of transthyretin-related amyloidosis.
    Type: Application
    Filed: November 28, 2018
    Publication date: November 19, 2020
    Inventors: Jay SOTO, Andrea HAWE, Ruedeeporn TANTIPOLPHAN, Stefan HEINDL
  • DOSING REGIMES FOR TREATMENT OF SYNUCLEINOPATHIES
    Publication number: 20190153102
    Abstract: The invention provides dosage regimes for treatment of synucleinopathies. In one regime, a subject receives 3000-5000 mg of an antibody intravenously every 3-5 weeks. In another regime, a subject receives 1300-1700 mg of an antibody intravenously every 3-5 weeks.
    Type: Application
    Filed: September 28, 2018
    Publication date: May 23, 2019
    Inventors: Jay Soto, Daniel Keith Ness, Martin Koller, Diane Mould, Frank Boess, Meret Martin-Fracklam, Valerie Cosson, Hans Peter Grimm, Ronald Gieschke, Sara Belli, Silke Weber